This report focuses on the global market of cell and tissue analysis (CTA) products and provides an updated review, including basic design and applications in various arenas of biomedical and life science research. The report deals with CTA products covering the total market, which includes three main areas of applications. These are biospecimen preparation techniques, cell separation products, and cell and tissue characterization products. These categories are further subdivided into various types. The report also covers the market for cell and tissue analysis products by end user. The end users of cell and tissue analysis products are categorized as research and academics, biopharmaceuticals, and healthcare and clinical. Excluded from this report are immunoassays.
The publisher analyzed each market and its application, regulatory environment, new products and advancements, patent analysis, market projections, and market shares. The current report provides a detailed analysis of the market’s drivers, challenges, opportunities, and impact of COVID-19. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments.
Report Includes
- 30 data tables and 20 additional tables
- A detailed overview and an up-to-date analysis of the global market for cell and tissue analysis (CTA) products and technologies
- Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Discussion of the industry growth driving factors and restraints that will shape the market for CTA products as the basis for projecting demand over the next few years (2022-2027)
- Estimation of the actual market size and revenue forecast for global cell and tissue analysis products market in USD millions, and corresponding market share analysis by type, application, end-user, and region
- Review of the commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
- Identification of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
- Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
- Information about patents and patent applications for cell and tissue analysis products and technologies by each major category
- Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
- Detailed company profiles of the leading industry players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Healthcare, Merck KGaA, PerkinElmer and Thermo Fisher Scientific Inc.
Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Scope of Report
1.3 Reason for Doing this Study
1.4 What's New in this Update?
1.5 Information Sources
1.6 Methodology
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 Custom Research
1.10 Related Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
3.1 Introduction
3.1.1 History
3.1.2 Cells
3.1.3 Animal Tissue
3.2 Classification of Techniques Used in Cell and Tissue Analysis
3.3 Biospecimen Techniques
3.3.1 Microarray
3.3.2 Tissue Microarrays
3.3.3 Cellular Microarray
3.3.4 Dna Microarray or Dna Chip
3.3.5 Protein Microarray or Peptide Chip
3.4 Cell-Separation Techniques
3.4.1 Mechanical and Physical Dissociation
3.4.2 Based on Adherence
3.4.3 Based on Size and Density
3.4.4 Based on Affinity
3.4.5 Lab-On-Chip Techniques
3.5 Cell and Tissue Characterization
3.5.1 Cell-Based Assays
3.5.2 Histology and Immunohistochemistry
3.5.3 Flow Cytometry
3.5.4 Genotyping and Expression Analysis
3.5.5 Western Analysis
3.5.6 Components of Cell-Based Assays
Chapter 4 Market Dynamics
4.1 Factors Affecting the Market
4.1.1 Market Drivers
4.1.2 Challenges for the Market for Cell and Tissue Analysis
4.1.3 Impact of the Covid-19 Pandemic
Chapter 5 Emerging Technologies
Chapter 6 Market Breakdown by Technology
6.1 Cell and Tissue Analysis Technologies
6.1.1 Biospecimen Technology
6.1.2 Cell Separation Technology
6.1.3 Cell and Tissue Characterization
Chapter 7 Market Breakdown by End-user
7.1 End-users
7.1.1 Biopharmaceutical Companies
7.1.2 Academic and Research Institutes
7.1.3 Healthcare and Clinical
Chapter 8 Market Breakdown by Region
8.1 North America
8.2 Europe
8.3 Emerging Markets
Chapter 9 Regulatory Aspects
9.1 New Approvals of Cell and Tissue Analysis Products
9.2 Recalls and Safety Alerts
Chapter 10 Patent Analysis
10.1 Patent Activity on Cell and Tissue Analysis
10.1.1 Patent Review by Year
10.1.2 Patent Review by Country
10.1.3 Patent Review by Company, University and Institute
Chapter 11 Competitive Landscape
11.1 Mergers and Acquisitions
11.2 Competitive Analysis
11.2.1 Biospecimen Technology
11.2.2 Cell Separation Technology
11.2.3 Cell and Tissue Characterization Technology
Chapter 12 Company Profiles
- Abcam plc
- Abnova Corp.
- Agilent Technologies Inc.
- Arrayit Corp.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corp.
- Carl Zeiss
- Cell Signaling Technology Inc.
- Danaher Corp.
- Fujifilm Cellular Dynamics Inc. (Fcdi)
- Ge Healthcare
- F. Hoffmann-La Roche AG
- Illumina Inc.
- Luminex Corp.
- Merck Kgaa
- Miltenyi Biotec
- Perkinelmer Inc.
- Sartorius AG
- Stemcell Technologies
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Worthington Biochemical Corp.
List of Tables
Summary Table B: Global Market for Cell and Tissue Analysis, by Region, Through 2027
Summary Table A: Global Market for Cell and Tissue Analysis, Through 2027
Table 1: History of Cell and Tissue Analysis
Table 2: Plant and Animal Cell Differences
Table 3: Prokaryotic and Eukaryotic Cell Differences
Table 4: Cell and Tissue Analysis Techniques
Table 5: Total Number of New Cases and Deaths Due to Various Cancers, Globally, 2020
Table 6: NIH Funding Estimated for Various Research, Condition and Disease Categories, 2017-2023
Table 7: Global Market for Cell and Tissue Analysis, Through 2027
Table 8: Global Market for Cell and Tissue Analysis, by Technology, Through 2027
Table 9: Global Market for Biospecimen Technology, by Type, Through 2027
Table 10: Global Market for Biospecimen Technology, by Region, Through 2027
Table 11: Global Market for Biospecimen Technology, by End User, Through 2027
Table 12: Global Market for Cell Separation Technology, by Type, Through 2027
Table 13: Global Market for Cell Separation Technology, by Region, Through 2027
Table 14: Global Market for Cell Separation Technology, by End User, Through 2027
Table 15: Global Market for Cell and Tissue Characterization Technology, by Type, Through 2027
Table 16: Global Market for Cell and Tissue Characterization Technology, by Region, Through 2027
Table 17: Global Market for Cell and Tissue Characterization Technology, by End User, Through 2027
Table 18: Global Market for Cell and Tissue Analysis, by End User, Through 2027
Table 19: Global Market for Biopharmaceutical Company End Users of Biospecimen Technology, by Region, Through 2027
Table 20: Global Market for Biopharmaceutical Company End Users of Cell Separation Technology, by Region, Through 2027
Table 21: Global Market for Biopharmaceutical Company End Users of Cell and Tissue Characterization Technology, by Region, Through 2027
Table 22: Cancer Research Grants, by Cancer Type, January 2023
Table 23: Global Market for Research Institute and Academic End Users of Biospecimen Technology, by Region, Through 2027
Table 24: Global Market for Research Institute and Academic End Users of Cell Separation Technology, by Region, Through 2027
Table 25: Global Market for Research Institute and Academic End Users of Cell and Tissue Characterization Technology, by Region, Through 2027
Table 26: Global Market for Healthcare and Clinical Laboratory End Users of Biospecimen Technology, by Region, Through 2027
Table 27: Global Market for Healthcare and Clinical Laboratory End Users of Cell Separation Technology, by Region, Through 2027
Table 28: Global Market for Healthcare and Clinical Laboratory End Users of Cell and Tissue Characterization Technology, by Region, Through 2027
Table 29: Global Market for Cell and Tissue Analysis, by Region, Through 2027
Table 30: New Approvals of Cell and Tissue Analysis Products, 2020-February 2023
Table 31: Recalls and Safety Alerts, 2019-2021
Table 32: Patents Issued for Cell and Tissue Analysis, by Year, 2020-2022
Table 33: Patents Issued on Cell and Tissue Analysis, by Country, 2020-2022
Table 34: Patents Issued on Cell and Tissue Analysis, by Organization, 2020-2022
Table 35: Mergers, Acquisitions and Collaborations, 2019-2022
Table 36: Key Companies in Biospecimen Technology
Table 37: Biospecimen Technology Market Leaders, 2021
Table 38: Key Companies in DNA Microarray Technology
Table 39: Key Companies in Protein Microarray Technology
Table 40: Key Players in Cell Separation Technology
Table 41: Competitive Analysis: Cell Separation Technology Market Leaders, 2021
Table 42: Key Companies in Magnetic Separation Technology
Table 43: Key Companies in Flow Cytometry Technology
Table 44: Key Companies in Cell and Tissue Characterization Technology
Table 45: Cell and Tissue Characterization Technology Market Leaders, 2021
Table 46: Key Companies in Cell-based Assays
Table 47: Key Companies in High-Content Screening (HCS) Technology
Table 48: Key Companies in Research Antibodies
List of Figures
Summary Figure A: Global Market for Cell and Tissue Analysis, 2019-2027
Summary Figure B: Global Market for Cell and Tissue Analysis, by Region, 2019-2027
Figure 1: Personalized Medicines as a Share of FDA Approvals, 2015-2021
Figure 2: Global Market for Cell and Tissue Analysis, by Technology, 2019-2027
Figure 3: Global Market Shares of Cell and Tissue Analysis, by Technology, 2021
Figure 4: Global Market for Biospecimen Technology, by Type, 2019-2027
Figure 5: Global Market Shares of Biospecimen Technology, by Type, 2021
Figure 6: Global Market for Biospecimen Technology, by Region, 2019-2027
Figure 7: Global Market for Biospecimen Technology, by End User, 2019-2027
Figure 8: Global Market for Cell Separation Technology, by Type, 2019-2027
Figure 9: Global Market Shares of Cell Separation Technology, by Type, 2021
Figure 10: Global Market for Cell Separation Technology, by Region, 2019-2027
Figure 11: Global Market for Cell Separation Technology, by End User, 2019-2027
Figure 12: Global Market for Cell and Tissue Characterization Technology, by Type, 2019-2027
Figure 13: Global Market Shares of Cell and Tissue Characterization Technology, by Type, 2021
Figure 14: Global Market for Cell and Tissue Characterization Technology, by Region, 2019-2027
Figure 15: Global Market for Cell and Tissue Characterization Technology, by End User, 2019-2027
Figure 16: Global Market for Cell and Tissue Analysis, by End User, 2019-2027
Figure 17: Global Market Shares of Cell and Tissue Analysis, by End User, 2021
Figure 18: Global Biopharmaceuticals R&D Spending, 2010-2024
Figure 19: Global Market for Biopharmaceutical Company End Users of Biospecimen Technology, by Region, 2019-2027
Figure 20: Global Market for Biopharmaceutical Company End Users of Cell Separation Technology, by Region, 2019-2027
Figure 21: Global Market for Biopharmaceutical Company End Users of Cell and Tissue Characterization Technology, by Region, 2019-2027
Figure 22: Global Market for Market for Research Institute and Academic End Users of Biospecimen Technology, by Region, 2019-2027
Figure 23: Global Market for Research Institute and Academic End Users of Cell Separation Technology, by Region, 2019-2027
Figure 24: Global Market for Research Institute and Academic End Users of Cell and Tissue Characterization Technology, by Region, 2019-2027
Figure 25: Global Market for Healthcare and Clinical Laboratory End Users of Biospecimen Technology, by Region, 2019-2027
Figure 26: Global Market for Healthcare and Clinical Laboratory End Users of Cell Separation Technology, by Region, 2019-2027
Figure 27: Global Market for Healthcare and Clinical Laboratory End Users of Cell and Tissue Characterization Technology, by Region, 2019-2027
Figure 28: Global Market for Cell and Tissue Analysis, by Region, 2019-2027
Figure 29: Global Market Shares of Cell and Tissue Analysis, by Region, 2021
Figure 30: Share of Patents Issued on Cell and Tissue Analysis, by Year, 2020-2022
Figure 31: Global Key Manufacturer/Supplier Market Shares of Cell and Tissue Analysis, 2021
Figure 32: Agilent Technologies: Annual Revenue, 2019-2021
Figure 33: Agilent Technologies’ Life Sciences and Applied Markets Segment: Annual Revenue, 2019-2021
Figure 34: Agilent Technologies’ Life Sciences and Applied Markets Segment: Revenue Share, by Region, 2021
Figure 35: Becton, Dickinson: Annual Revenue, 2019-2021
Figure 36: Becton, Dickinson’s Biosciences Segment: Annual Revenue, 2019-2021
Figure 37: Becton, Dickinson: Revenue Share, by Region, 2021
Figure 38: Bio-Rad Laboratories Inc.: Annual Revenue, 2019-2021
Figure 39: Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2021
Figure 40: Bio-Rad Laboratories Inc.: Revenue Share, by Geography, 2021
Figure 41: Bio-Techne Corp.: Annual Revenue, 2019-2021
Figure 42: Bio-Techne Corp.: Market Share, by Business Segment, 2021
Figure 43: Bio-Techne Corp.: Revenue Share, by Region, 2021
Figure 44: Danaher Corp.: Annual Revenue, 2019-2021
Figure 45: Danaher Corp.: Market Share, by Region, 2021
Figure 46: Danaher Corp.: Market Share, by Business Segment, 2021
Figure 47: General Electric Healthcare: Annual Revenue, 2019-2021
Figure 48: General Electric Healthcare: Revenue Share, by Region, 2021
Figure 49: General Electric Healthcare: Revenue Share, by Business Segment, 2021
Figure 50: Roche Diagnostics Corp.: Annual Revenue, 2019-2021
Figure 51: Roche Diagnostics Corp.: Market Share, by Region, 2021
Figure 52: Roche Diagnostics Corp.: Market Share, by Business Segment, 2021
Figure 53: Illumina Inc.: Annual Revenue, 2019-2021
Figure 54: Illumina Inc.: Market Share, by Region, 2021
Figure 55: Illumina Inc.: Market Share, by Business Segment, 2021
Figure 56: Merck KGaA: Annual Revenue, 2019-2021
Figure 57: Merck KGaA: Revenue Share, by Region, 2021
Figure 58: Merck KGaA: Revenue Share, by Business Segment, 2021
Figure 59: PerkinElmer: Annual Revenue, 2019-2021
Figure 60: PerkinElmer: Revenue Share, by Region, 2021
Figure 61: PerkinElmer: Revenue Share, by Business Unit, 2021
Figure 62: Sartorius: Annual Revenue, 2019-2021
Figure 63: Sartorius: Market Share, by Region, 2021
Figure 64: Sartorius: Market Share, by Business Segment, 2021
Figure 65: Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
Figure 66: Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
Figure 67: Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021
Executive Summary
Cell and tissue analysis products are playing pivotal roles in biomedical research. In the expanding field of biomedical research and development researchers and scientists employ a variety of cell and tissue analysis products. These products play important roles in the diagnosis of various forms of cancer and other diseases and also assume crucial roles when it comes to understanding diverse cellular activities. With the rise of chronic and infectious diseases, there is an urgent need for efficient diagnostics and better healthcare conditions to treat diseases. Along with the recent intensification of research in academia and the biomedical industry, demand is increasing significantly for advanced technology for drug development and screening.
Personalized drug treatment is becoming a reality. In response to the rise in the incidence of a number of diseases and an ageing population, the drug discovery industry is developing new and more efficacious drugs based on specific biomarker signatures and hence cell and tissue analysis technologies will also help in personalized drug development.
Apart from this the increasing demand for single-cell analysis and the extensive research ongoing in this area will further contribute to the market. Other drivers contributing to the market include advances in technologies and product launches, increasing prevalence of chronic diseases, an ageing population, and rising investments and funding. However, the market is facing some challenges such as the high cost of instruments, lack of skilled labor and stringent regulations.
The global market for cell and tissue analysis was estimated to be $16.7 billion in 2021 and is expected to increase to $28.9 billion in 2027, growing at a CAGR of 9.6% during the forecast period. In this report the cell and tissue analysis market is segmented based on technology type, end user and region. Major players in the market are Thermo Fisher Scientific, Danaher, Becton, Dickinson & Co., Illumina, and Agilent Technologies. Technology types covered are biospecimen technology, cell separation, and cell and tissue characterization. Based on type, the cell and tissue characterization segment has the highest share. Each type is further categorized into subtypes.
North America has the highest share of the market by region, followed by Europe. Extensive R&D activities take place in the region, there are major players present, there is plentiful funding, and there is an increasing prevalence of chronic diseases. All these factors will contribute to growth in the market
Companies Mentioned
- Abcam plc
- Abnova Corp.
- Agilent Technologies Inc.
- Arrayit Corp.
- Becton, Dickinson & Co.
- Bio-Rad Laboratories Inc.
- Bio-Techne Corp.
- Carl Zeiss
- Cell Signaling Technology Inc.
- Danaher Corp.
- F. Hoffmann-La Roche AG
- Fujifilm Cellular Dynamics Inc. (Fcdi)
- Ge Healthcare
- Illumina Inc.
- Luminex Corp.
- Merck Kgaa
- Miltenyi Biotec
- Perkinelmer Inc.
- Sartorius AG
- Stemcell Technologies
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Worthington Biochemical Corp.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 151 |
| Published | March 2023 |
| Forecast Period | 2022 - 2027 |
| Estimated Market Value ( USD | $ 18.2 Billion |
| Forecasted Market Value ( USD | $ 28.9 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
